Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for spinal fusion.

Frank M Phillips1, Patrick M Bolt, Tong-Chuan He

  • 1Rush University Medical Center, 1725 West Harrison Street, Suite 1063, Chicago, IL 60612, USA. frank.phillips@rushortho.com

The Spine Journal : Official Journal of the North American Spine Society
|November 18, 2005
PubMed
Summary

Spinal fusion surgery faces challenges like donor site morbidity. Gene therapy offers a promising biologic approach to enhance bone formation and improve spinal fusion rates, though further research is needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility and Early Safety of Single-Position Lateral Lumbar Interbody Fusion With Posterior Pedicle Screw Instrumentation and Fusion at the Ambulatory Surgery Center: A Preliminary Case Series.

International journal of spine surgery·2026
Same author

Early Clinical Safety Profile and Accuracy of Augmented Reality-Assisted Pedicle Screw Placement: A Multi-Center Analysis of 200 Screws.

Clinical spine surgery·2026
Same author

Endocrine therapy resistance of breast cancer: Important role of G protein-coupled estrogen receptor (GPER) and new therapeutic strategies.

Genes & diseases·2025
Same author

Return-to-Sport Recommendations in Athletes Requiring Cervical Spine Surgery: A Modified Delphi Consensus Survey of Expert Opinion.

Spine·2025
Same author

Author Response to Letter to Editor: "Degenerative disc disease and isthmic spondylolisthesis have similar outcomes after L5-S1 anterior lumbar interbody fusion".

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2025
Same author

Return-to-Sport Recommendations for Athletes With Congenital Cervical Spine Pathology: A Modified Delphi Consensus Survey of Expert Opinion.

Neurosurgery·2025

Area of Science:

  • Orthopedics
  • Regenerative Medicine
  • Biotechnology

Background:

  • Spinal fusion is crucial for treating spinal pathology but faces challenges such as autograft donor site morbidity and pseudoarthrosis.
  • Current therapeutic biologics like recombinant bone morphogenetic proteins have limitations including cost and efficacy in complex fusion scenarios.

Purpose of the Study:

  • To explore gene therapy as a novel and potentially simpler method for delivering bone-forming agents to promote spinal fusion.
  • To review the potential of in vivo and ex vivo gene delivery techniques in enhancing spinal fusion outcomes.

Main Methods:

  • Review of existing literature on therapeutic biologics and gene therapy for spinal fusion.
  • Analysis of in vivo and ex vivo gene delivery techniques in preclinical animal models.

Related Experiment Videos

Main Results:

  • Recombinant bone morphogenetic proteins show limited success in challenging fusion cases and are expensive.
  • In vivo and ex vivo gene therapy techniques have demonstrated effectiveness in promoting spinal fusion in animal studies.

Conclusions:

  • Gene therapy presents a potentially easier and more effective method for applying bone-forming biologics in spinal fusion.
  • Further research is essential to develop safe and effective gene therapy techniques and vectors for successful spinal fusion in humans.